Antibody neutralization and escape by HIV-1
- PMID: 12646921
- DOI: 10.1038/nature01470
Antibody neutralization and escape by HIV-1
Abstract
Neutralizing antibodies (Nab) are a principal component of an effective human immune response to many pathogens, yet their role in HIV-1 infection is unclear. To gain a better understanding of this role, we examined plasma from patients with acute HIV infection. Here we report the detection of autologous Nab as early as 52 days after detection of HIV-specific antibodies. The viral inhibitory activity of Nab resulted in complete replacement of neutralization-sensitive virus by successive populations of resistant virus. Escape virus contained mutations in the env gene that were unexpectedly sparse, did not map generally to known neutralization epitopes, and involved primarily changes in N-linked glycosylation. This pattern of escape, and the exceptional density of HIV-1 envelope glycosylation generally, led us to postulate an evolving 'glycan shield' mechanism of neutralization escape whereby selected changes in glycan packing prevent Nab binding but not receptor binding. Direct support for this model was obtained by mutational substitution showing that Nab-selected alterations in glycosylation conferred escape from both autologous antibody and epitope-specific monoclonal antibodies. The evolving glycan shield thus represents a new mechanism contributing to HIV-1 persistence in the face of an evolving antibody repertoire.
Similar articles
-
[Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].Enferm Infecc Microbiol Clin. 2009 Nov;27(9):523-30. doi: 10.1016/j.eimc.2008.02.010. Epub 2009 May 1. Enferm Infecc Microbiol Clin. 2009. PMID: 19409660 Review. Spanish.
-
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.Science. 2004 Mar 26;303(5666):2019-22. doi: 10.1126/science.1093137. Science. 2004. PMID: 15044802
-
An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.Virology. 1993 Sep;196(1):332-7. doi: 10.1006/viro.1993.1484. Virology. 1993. PMID: 8356803
-
Epitopes of HIV-1 glycoproteins recognized by the human immune system.Chem Immunol. 1993;56:91-111. Chem Immunol. 1993. PMID: 7680869 Review. No abstract available.
-
Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.AIDS. 1994 Feb;8(2):169-81. AIDS. 1994. PMID: 7519019
Cited by
-
Characterization and application of recombinant Bovine Leukemia Virus Env protein.Sci Rep. 2024 May 28;14(1):12190. doi: 10.1038/s41598-024-62811-8. Sci Rep. 2024. PMID: 38806566 Free PMC article.
-
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.Nat Commun. 2024 May 21;15(1):4301. doi: 10.1038/s41467-024-48514-8. Nat Commun. 2024. PMID: 38773089 Free PMC article.
-
Current situation in the development of a preventive HIV vaccine.Enferm Infecc Microbiol Clin. 2005 Jul;23:15-24. doi: 10.1016/S0213-005X(05)75157-0. Epub 2009 Jan 6. Enferm Infecc Microbiol Clin. 2005. PMID: 38620211 Free PMC article.
-
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines.NPJ Vaccines. 2024 Apr 6;9(1):74. doi: 10.1038/s41541-024-00862-8. NPJ Vaccines. 2024. PMID: 38582771 Free PMC article.
-
The cell biology of HIV-1 latency and rebound.Retrovirology. 2024 Apr 5;21(1):6. doi: 10.1186/s12977-024-00639-w. Retrovirology. 2024. PMID: 38580979 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases